Cognitive Behavioral Therapy for Patients with Trigeminal Neuralgia: A Feasibility Study

Aims: To test the feasibility and acceptability of a customized six-session cognitive behavioral therapy (CBT) group intervention for adults with recurrent trigeminal neuralgia (TN). Methods: Fifteen participants with TN were recruited from a specialist facial pain unit in London, United Kingdom. The effects of the group intervention were evaluated using validated self-report measures, which the participants completed before and after the intervention and at 1-month and 9-month follow-ups. A semi-structured interview was also used at the 1-year follow-up to gather qualitative feedback of the group intervention. Results: Participants reported an increase in confidence in managing everyday tasks in the presence of TN symptoms, a reduction in negative beliefs about pain, and an increase in engagement in meaningful activity. All patients completed the group intervention (100% retention rate). Qualitative feedback highlighted that the group CBT intervention was helpful, and no participants reported a worsening of mood or experience as a result of the intervention. Conclusion: The trends for improvement in several domains, plus the positive experiences of the participants, suggest that a CBT management program is acceptable and feasible for this population and should be further developed and implemented on a larger scale to determine its clinical efficacy.

cognitive behavioral therapy; facial pain; fear; pain management; multidisciplinary; patient satisfaction; quality of life; trigeminal neuralgia

1. Cruccu G, Finnerup N, Jensen TS, et al. Trigeminal neuralgia. Neurology 2016;87:220–228.

2. Allsop MJ, Twiddy M, Grant H, et al. Diagnosis, medica-tion, and surgical management for patients with trigemi nal neuralgia: A qualitative study. Acta Neurochir (Wien) 2015;157:1925–1933.

3. Macˇianskyte˙ D, Janužis G, Kubilius R, Adomaitiene˙ V, Šcˇiupokas A. Associations between chronic pain and depres sive symptoms in patients with trigeminal neuralgia. Medicina (Kaunas) 2011;47:386–392.

4. Castro AR, Siqueira SR, Perissinotti DM, Siqueira JT. Psychological evaluation and cope with trigeminal neural gia and temporomandibular disorder. Arq Neuropsiquiatr 2008;66:716–719.

5. Tang Y, Ma L, Li N, et al. Percutaneous trigeminal ganglion radiofrequency thermocoagulation alleviates anxiety and de pression disorders in patients with classic trigeminal neural-gia: A cohort study. Medicine (Baltimore) 2016;95:e5379.

6. Zakrzewska J, Palmer J, Morisset V, et al. Safety and effica cy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: A double-blind, placebo-con trolled, randomised withdrawal phase 2a trial. Lancet Neurol 2017;16:291–300.

7. Zakrzewska JM, Linskey ME. Trigeminal neuralgia. BMJ 2014;348:g474.

8. Moisset X, Villain N, Ducreux D, et al. Functional brain imaging of trigeminal neuralgia. Eur J Pain 2011;15:124–131.

9. Wang Y, Cao DY, Remeniuk B, Krimmel S, Seminowicz DA, Zhang M. Altered brain structure and function associated with ensory and affective components of classic trigeminal neural-gia. Pain 2017;158:1561–1570.

10. Spina A, Mortini P, Alemanno F, Houdayer E, Iannaccone S. Trigeminal neuralgia: Toward a multimodal approach. World eurosurg 2017;103:220–230.

11. Maarbjerg S, Gozalov A, Olesen J, Bendtsen L. Concomitant persistent pain in classical trigeminal neuralgia Evidence for different subtypes. Headache 2014;54:1173–1183.

12. Zakrzewska JM, Padfield D. The patient’s journey through tri-geminal neuralgia. Pain: Clinical Updates 2014;22:1–7.

13. Mueller D, Obermann M, Yoon MS, et al. Prevalence of trigem inal neuralgia and persistent idiopathic facial pain: A popula-tion-based study. Cephalalgia 2011;31:1542 1548.

14. Williams AC, Eccleston C, Morley S. Psychological therapies for the management of chronic pain (excluding headache) in dults. Cochrane Database Syst Rev 2012;11(11):CD007407.

15. Vlaeyen JW, Morley S. Cognitive-behavioral treatments for chronic pain: What works for whom? Clin J Pain 2005;21:1 8.

16. Nicholas, MK. The pain self-efficacy questionnaire: Taking pain into account. Euro J Pain 2007;11:153–163.

17. Pincus T, Williams AC, Vogel S, Field A. The development and testing of the depression, anxiety and positive outlook scale (DAPOS). Pain 2004;109:181–188.

18. Sullivan MJ, Bishop SR, Pivik J. The Pain Catastrophizing Scale: Development and validation. Psychol Assess 1995;7:524–532.

19. McCracken L, Vowles K, Eccleston C. Acceptance of chronic pain: Component analysis and a revised assessment method. Pain 2004;107:159–166.

20. Von Korff M, Ormel J, Keefe FL, Dworkin SF. Grading the severity of chronic pain. Pain 1992;50:133–149.

21. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: Recommendations for good practice. J Eval Clin Pract 2004;10:307–312.

22. Eldridge SM, Lancaster GA, Campbell MJ, et al. Defining feasibility and pilot studies in preparation for randomised controlled trials: Development of a conceptual framework. PLoS One 2016;11:e0150205.

23. Nova CV, Zakrzewska JM, Baker SR, Riordain RN. Treatment outcomes in trigeminal neuralgia—A systematic review of domains, dimensions and measures. World Neurosurg X 2020;6:100070.